Sangamo Therapeutics to Present Neurology-Focused Pre-Clinic

Sangamo Therapeutics, Inc. , a genomic medicine company, today announced that the American Society of Gene & Cell Therapy has accepted 20 Sangamo abstracts for presentation at the 27th ASGCT Annual...

Related Keywords

Kamy Pooler , Greg Davis , American Society Of Gene Cell Therapy , Development Of Blood , Head Of Research At Sangamo , Development Of Modular Integrases Mints , Nasdaq , Head Of Technology At Sangamo , Sangamo Therapeutics Inc , Formulation Development , Linkedin , Exchange Commission , Sangamo Therapeutics , American Society , Cell Therapy , Modular Integrases , Dravet Syndrome , Meeting Presentations , Central Nervous , Normal Gene , Protein Expression , Human Disease Models , Haploinsufficiency Using Zinc Finger Activators , Zinc Finger Activator Platform , Restore Normal Gene , Cellular Models , Repression Mediated , Zinc Finger Repressors , Therapeutic Approach , Gene Activation Mediated , Zinc Finger Activators , Angelman Syndrome , Tau Knockdown , Potential Treatment , Activation Mediated , Zinc Finger Transcriptional Activators , Phelan Mcdermid Syndrome , Robust Zinc Finger Activation Platform , Neurological Disorders , Human Prion Expression , Potential One Time Treatment , Prion Disease , That Exhibits Widespread Transduction , Central Nervous System , Cynomolgus Macaques , Highly Potent Engineered , Enables High Throughput , Arrayed Epigenetic Regulator Screening Directly , Cultured Neurons , Drug Product Presentation , Container Closure Selection , Based Genomic Medicines , Blood Brain Barrier Penetrant , Receptor Targeted Capsid Engineering , Manufacturing Process Related Stresses , Novel Blood Brain Barrier Penetrant , Finger Mediated Repression , Cellular Disease Phenotype , Patient Derived Cells , Specific Zinc Finger Proteins , Dosage Sensitive Transgenes , Annual Report , Markets ,